STAT+: Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in studies

Coverage, in order

1. 2d ago
   
   first STAT News indie study

   STAT+: Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in studies

   Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in two late-stage studies, but it doesn’t appear as effective as Lilly’s injectable drug Zepbound. In a one-year trial of patients who weren’t receiving PAP therapy, a form of ventilation, those on Foundayo saw a reduction of 17.8…

2. 2d ago
   
   AHA Newsroom indie

   Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight

   Research Highlights: In two, separate, year-long clinical trials, adults with moderate-to-severe sleep apnea and excess weight (BMI ≥27 kg/m²) who took the oral GLP-1 medication orforglipron, had about 18 fewer breathing interruptions per hour of...

3. 2d ago
   Scientific American (global) indie

   Eli Lilly shows GLP-1 weight-loss pill Foundayo can dramatically improve sleep apnea

   Foundayo, a daily pill, successfully reduced obstructive sleep apnea, according to clinical trial data

4. 2d ago
   
   Healio indie

   Oral GLP-1 reduces sleep apnea severity, cardiometabolic risk

   CHICAGO — Adults with moderate to severe obstructive sleep apnea and overweight or obesity who used the oral GLP-1 orforglipron for 1 year experienced improvements in sleep apnea severity, according to results from the ATTAIN-OSA trials. Orforglipron (Foundayo, Eli Lilly) also conferred improvement…

5. 1d ago
   
   Medical Xpress indie

   Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight

   Adults with moderate-to-severe sleep apnea and excess weight had significantly fewer episodes of breathing interruptions while sleeping after taking the daily oral GLP-1 medication orforglipron for one year, compared with adults in the placebo group, according to new, independent, preliminary…

6. 1d ago
   
   MedPage Today indie randomized trial

   GLP-1 Pill Shows Benefit in Sleep Apnea

   (MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity, two phase III trials showed. For the treatment...

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.